← Open Payments lookup

GARRICK TONG: Open Payments

NPI 1831361278 · SAN MARCOS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,304 in 66 payments from 13 companies in 2025. Trend: 2023 $1,342 · 2024 $1,312 · 2025 $1,304

Food & beverage: $1,304
CompanyPaymentsAmount
Supernus Pharmaceuticals, Inc.17$302
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$222
Otsuka America Pharmaceutical, Inc.9$160
Alkermes, Inc.6$121
Neurocrine BioSciences, Inc.3$106
E.R. Squibb & Sons, L.L.C.4$99
Teva Pharmaceuticals USA, Inc.3$79
Collegium Pharmaceutical, Inc.3$67
Lundbeck LLC3$56
Axsome Therapeutics, Inc.1$32

Products named: Qelbree, CAPLYTA, REXULTI, ARISTADA, INGREZZA, COBENFY, ABILIFY ASIMTUFII, AUSTEDO XR.

Industry payments across CA — which companies pay providers there.